Chemistry & Industry. 2014;78:28
A Roadmap for Risk
Chemistry & Industry, 2014
Open access, peer-reviewed publications ensure that knowledge is a public good. HESI believes that accessible research is critical for equitable engagement, diverse collaboration, and increased interdisciplinary conversation. We strive to achieve open access on all publications, and more than 200 publications from HESI programs have been published in the last decade.
Chemistry & Industry, 2014
Chemistry & Industry. 2014;78:28
Environmental Toxicology and Chemistry, 2009
An evaluated database of whole body in vivo biotransformation rate estimates in fish was used to develop a model for predicting the primary biotransformation half-lives of organic chemicals.
Journal of Pharmacological and Toxicological Methods, 2013
The evaluation of cardiovascular side-effects is a critical element in the development of all new drugs and chemicals.
Toxicological Sciences, 2005
A group of thirty immunotoxicology experts from the U.S. and E.U. representing government, industry, and academia met in May 2003, in Washington, D.C., to reach consensus regarding the most appropriate methods to assess developmental immunotoxicology (DIT) for hazard identification, including under what conditions such ...
Critical Reviews in Toxicology, 2011
Quantitative methods for estimation of cancer risk have been developed for daily, lifetime human exposures.
International Journal of Toxicology, 2018
Results from this limited retrospective electrocardiogram analysis suggest that JTpca and Tpeca may discriminate selective IKr blockers and multichannel blockers and could be considered in the context of an integrated comprehensive proarrhythmic risk assessment.
hesi@hesiglobal.org
Phone: +1-202-659-8404
Fax: +1-202-659-3859
740 15th Street NW, Suite 600
Washington, DC 20005
Sign up for our monthly e-newsletter.